Cagrilintide: Sourcing, Purity, and Verification Standards
An analytical account of how cagrilintide, an acylated amylin-analog peptide, is synthesized, purified, and verified for research use. Educational reference.
cagrilintidesourcingquality
Research library
Peptide research library
Published literature, mechanisms, and protocols, organized by compound. Educational reference, not medical advice.
All articles
Cagrilintide: Published Research
A literature-anchored walk through cagrilintide's published record, from the acylated amylin-analog design that solved fibrillation, to the Phase 1b and Phase 2 combination trials, the Phase 3 REDEFINE readouts, and cryo-EM receptor structures. Educational reference.
cagrilintideamylinclinical-trial
Cagrilintide: A Research Overview
How cagrilintide (AM833) re-engineers the amylin scaffold: the amyloid-fibril problem in native amylin, the C20 acylation strategy behind extended circulation, and its place in the CagriSema program. Educational reference.
cagrilintideamylinamylin-analog
Cagrilintide Mechanism of Action
A chemistry-first account of cagrilintide's reported pharmacology: how its lipidation, backbone substitutions, and pH-neutral design map onto the calcitonin/amylin (RAMP) receptor family described in peer-reviewed literature. Educational reference.
cagrilintideamylincalcitonin-receptor
Cagrilintide: Discovery and Regulatory History
How cagrilintide (AM833) grew out of amylin pharmacology, from the peptide's 1987 identification and the non-amyloidogenic analog chemistry behind pramlintide to the acylation strategy and REDEFINE trials that carried it to a 2025 FDA filing.
cagrilintideamylinamylin-analog
BPC-157: Sourcing, Purity, and Verification Standards
A sourcing reference for BPC-157: how its proline-rich sequence shapes solid-phase synthesis, HPLC and mass-spectrometry release testing, salt form, and certificate-of-analysis review. Educational reference.
bpc-157sourcingquality
BPC-157: Published Research
A critical bibliographic tour of the BPC-157 literature: its single-lineage provenance, the gastrointestinal and tendon-fibroblast studies, the nitric-oxide hypothesis, pharmacokinetic data, and the unresolved replication and human-evidence questions.
bpc-157preclinical-researchmusculoskeletal
BPC-157: A Research Overview
An educational overview of BPC-157, the proline-rich pentadecapeptide derived from a human gastric-juice protein: its sequence, acid-stable chemistry, pharmacokinetic profile, and the Zagreb research lineage that characterized it. Educational reference.
bpc-157pentadecapeptidecytoprotection
BPC-157 Mechanism of Action
A pathway-by-pathway mechanistic review of BPC-157, tracing the Src-Cav-1-eNOS, VEGF, FAK-paxillin, and growth-hormone-receptor interactions documented in peer-reviewed preclinical literature. Educational reference.
bpc-157mechanism-of-actionnitric-oxide
BPC-157: Discovery and Regulatory History
How BPC-157 traveled from a 1993 gastric-cytoprotection hypothesis at the University of Zagreb, through Pliva's PL14736 clinical program, to research-use-only status and a 2022 WADA Monitoring Program listing. Educational reference.
bpc-157discovery-historyregulatory-history
AOD9604: Sourcing, Purity, and Verification Standards
A chemistry-first look at verifying AOD9604: why its modified hGH 177-191 sequence and single disulfide bridge shape the synthesis and analytical methods used to confirm identity and purity. Educational reference.
aod9604sourcingquality
AOD9604: Published Research
A thread-by-thread survey of the peer-reviewed AOD9604 literature: the antilipogenesis-versus-lipolysis question, the β3-adrenergic receptor line of study, the oral-activity puzzle, and the consolidated six-trial human safety dataset.
aod9604published-researchclinical-trials
AOD9604: A Research Overview
How a 16-residue synthetic peptide isolated the lipid-regulatory tail of human growth hormone: the design logic behind AOD9604, its receptor-independence question, and the six-trial human safety record that shaped its regulatory path.
aod9604growth-hormone-fragmentlipolysis-research
AOD9604 Mechanism of Action
A mechanism-focused reference on AOD9604, the tyrosinated hGH 177-191 fragment: why the isolated C-terminal domain reportedly reproduces the fat-metabolizing actions of growth hormone in preclinical models while bypassing the growth-hormone receptor, IGF-1 output, and the diabetogenic effects of the intact hormone.
aod9604mechanism-of-actionlipolysis-research
AOD9604: Discovery and Regulatory History
A chronological reference on AOD9604, tracing a single scientific question at Monash University about the growth-hormone C-terminus into a stabilized hexadecapeptide, six controlled human trials, the OPTIONS endpoint outcome, a US FDA GRAS pivot, and its status under anti-doping regulation.
aod9604discovery-historyregulatory-history